Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dachengqi decoction plus probiotic for gastrointestinal dysfunction after severe trauma
ChiCTR-TRC-13003248Phase 4Completed
- Sponsor
- Army Medical University School of Nursing
- Start
- May 2013
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis and Dachengqi Decoction in Digestive tract dysfunction (3 arms), sponsored by Army Medical University School of Nursing. Primary endpoints: D-lactic acid, motilin and 2 more. Started May 2013; status: completed.
02
Drugs
bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalisDachengqi Decoction
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on ChiCTR-TRC-13003248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003248.